- P-ISSN 1225-0163
- E-ISSN 2288-8985
참당귀 추출물의 골관절염에 대한 억제 또는 치료효과를 알고자 monosodium iodoacetate로 유발한 흰쥐의 골관절염 모델을 사용하여 30마리 6주령 SD흰쥐를 정상군(normal), 비처리군(untreated) 및참당귀 처리군(treated)으로 각각 10마리씩 나누어 실험하였다. 실험기간 동안 실험 개시일부터 4일간격으로 체중 변화를 측정하였다. 3주간 참당귀 추출물 처리 후 관절연골 내의 glycosaminoglycan (GAG)의 함량 및 proteoglycan (PG) 함량을 측정 비교하였다. 그 결과, 참당귀 추출물은 MIA로 증가한 GAG를 완화시켰으며, PG의 함량을 회복시켰다. 또한, 활액에서의 TNF-a함량은 미약하게 감소하였다. 한편, 경골 관절연골을 분리하여 Safranin-O 염색으로 관절연골 상태를 확인한 결과, MIA 처리로 유발된 관절연골 소실을 억제하였다. 이 참당귀 추출물을 HPLC로 분석한 결과, 주요 성분인 decursin 및 decursinolangelate의 총 함량은 10.5 ± 0.2%이었다.
To study the efficacy of extract powder of Angelica gigas in preventing and treating degeneration of thearticular cartilage in rats with monosodium iodoacetate (MIA)-induced osteoarthritis, A total of 30 six-week-oldSprague-Dawley rats were randomly divided into normal control group, untreated group and Angelica gigas treatedgroup, with 10 rats in each group. During the treatment period, body weight were measured in each four days intervalfrom starting date. The rat were sacrificed at the end of 3rd week after daily administration of Angelica gigas andthen rat tibia articular cartilage was removed. In articular cartilages, glycosaminoglycan (GAG) amount increasedby MIA treatment were reduced while proteoglycan (PG) amount decreased by MIA treatment were fairly recoveredby Angelica gigas treatment, respectively. The content of TNF-a was also slightly reduced sections of the cartilagewere stained with safranin-0 were also partially recovered by Angelica gigas treatment. By HPLC analysis, the contentof main compounds decursin and decursinol angelate was analyzed as 10.5 ± 0.2% of total extracts.
1. M. Konoshima, H. J. Chi and K. Hata, Chem. Pharm. Bull. (Tokyo), 16(6), 1139-1140 (1968).
2. K. S. Ahn, W. S. Sim and I. H. Kim, Planta Med., 62(1), 7-9 (1996).
3. K. S. Ahn, W. S. Sim, I. K. Lee, Y. B. Seu and I. H. Kim, Planta Med., 63(4), 360-361 (1997).
4. A. Tsezou, Osteoarthritis Cartilage, 22(12), 2017-2024 (2014).
5. A. Migliore and U. Massafra, Clin Cases Miner Bone Metab., 11(2), 114-116 (2014).
6. M. Luo, J. Chen, S. Li, H. Sun, Z. Zhang, Q. Fu, J. Li, J. Wang, C. E. Hughes, B. Caterson and J. Cao, Osteoarthritis Cartilage, 22(7), 986-995 (2014).
7. W. Rahman and A. H. Dickenson, Arthritis Res. Ther., 16(6), 509-512 (2014).
8. G. M. van Buul, M. Siebelt, M. J. Leijs, P. K. Bos, J. H. Waarsing, N. Kops, H. Weinans, J. A. Verhaar, M. R. Bernsen and G. J. van Osch, J. Orthop Res., 32(9), 1167-1174 (2014).
9. R. D. Bowles, B. A. Mata, R. D. Bell, T. K. Mwangi, J. L. Huebner, V. B. Kraus, L. A. Setton, Arthritis Rheumatol., 66(3), 637-646 (2014).
10. J. K. Kim, T. H. Kim, S. W. Park, H. Y. Kim, S. H. Kim, S. Y. Lee and S. M. Lee, Biol. Pharm. Bull., 33(6), 1004-1010 (2010).
11. T. Thote, A. S. Lin, Y. Raji, S. Moran, H. Y. Stevens, M. Hart, R. V. Kamath, R. E. Guldberg and N. J. Willett, Osteoarthritis Cartilage, 21(8), 1132-1141 (2013).
12. W. Wu, X. Xu, Y. and L. Xia, Phytother Res., 24(4), 538-546 (2010).
13. S. Colen, P. Geervliet, D. Haverkamp, M. P. Van Den Bekerom, Int. J. Shoulder Surg., 8(4), 114-121 (2014).
14. X. Wang, D. Hunter, J. Xu and C. Ding, Osteoarthritis Cartilage, 23(1), 22-30 (2015).
15. M. Ishijima, H. Kaneko and K. Kaneko, Ther Adv Musculoskelet Dis., 6(4), 144-153 (2014).
16. R. X. Zhang, K. Ren and R. Dubner, Osteoarthritis Cartilage, 21(9), 1308-1315 (2013).